Medication Treatment for Depression in Nursing Home Residents
NCT00076622 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94
Last updated 2018-01-31
Summary
This study will examine therapeutic and adverse effects of continuing versus discontinuing antidepressant medication in nursing home residents who have had no more than a single episode of depression and who no longer have depressive symptoms.
Conditions
Interventions
- DRUG
-
Antidepressant medication
Participants assigned to continue current medication will be monitored over a period of one year for recurrence of depression and related symptoms.
- DRUG
-
No antidepressant medication
Participants assigned to discontinue current medication (no antidepressant medication) will be monitored over a period of one year for recurrence of depression and related symptoms.
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH - lead OTHER
Principal Investigators
-
Joel E. Streim, MD · University of Pennsylvania
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-11-30
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- United States
Study Locations
More Related Trials
-
Pharmacogenetic and Antidepressant Treatment in Elderly
NCT02856477 ·Status: TERMINATED ·Phase: NA
-
Effectiveness of a Depression Care Management Initiative in Home Healthcare
NCT01979302 ·Status: UNKNOWN ·Phase: NA
-
Treating Alcohol Use In Older Adults With Depression
NCT00018824 ·Status: COMPLETED ·Phase: PHASE4
-
Symptom Tracking in Assisted Reproductive Technologies
NCT01746797 ·Status: COMPLETED
-
Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression
NCT00178100 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
NCT00285766 ·Status: COMPLETED ·Phase: PHASE3
-
Preventing Depression in Patients With Macular Degeneration
NCT00042211 ·Status: COMPLETED ·Phase: PHASE3
-
Primary Prevention of Major Depression in Later Life
NCT00326677 ·Status: COMPLETED ·Phase: NA
-
Prevention of Suicide in Primary Care Elderly: Collaborative Trial (PROSPECT)
NCT00279682 ·Status: COMPLETED ·Phase: PHASE4
-
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
NCT05877885 ·Status: RECRUITING ·Phase: NA
-
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
NCT02330679 ·Status: UNKNOWN ·Phase: PHASE4
-
Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users
NCT00228007 ·Status: COMPLETED ·Phase: PHASE3
-
Exercise Training Versus Drug Therapy for Treating Depression in Older Adults
NCT00331305 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Collaborative Care in General Practice for Elderly Patients With Depression
NCT04078282 ·Status: COMPLETED ·Phase: NA
-
Shared Decision-Making for Elderly Depressed Primary Care Patients
NCT01031134 ·Status: COMPLETED ·Phase: NA
-
L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
NCT03761030 ·Status: TERMINATED ·Phase: PHASE4
-
Secondary Prevention of Depression Applying an Experimental Attentional Bias Modification Procedure
NCT02658682 ·Status: COMPLETED ·Phase: NA
-
Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial
NCT06626152 ·Status: RECRUITING ·Phase: PHASE2
-
Lonely in Depression
NCT07333027 ·Status: RECRUITING
-
Feasibility of Depression Care Management by E-mail
NCT00755235 ·Status: COMPLETED ·Phase: NA
-
Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression
NCT00157547 ·Status: COMPLETED ·Phase: PHASE4
-
Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
NCT00183729 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Observation of Participants With Mood Disorders
NCT04877977 ·Status: RECRUITING
-
Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression
NCT00926653 ·Status: COMPLETED
-
Pilot Study of Open-label Placebo to Treat Major Depressive Disorder
NCT01103271 ·Status: COMPLETED ·Phase: PHASE2